Chemomab Therapeutics Ltd. — All Filings
336 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
15-15D
20-F
20-F/A
3
4
424B3
424B4
424B5
425
6-K
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
F-3/A
F-4
F-4/A
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | OWNERSHIP DOCUMENT | 0001104659-20-000367 | Jan 2, 2020 | Jan 1, 2020 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-20-000366 | Jan 2, 2020 | Jan 1, 2020 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-20-000365 | Jan 2, 2020 | Jan 1, 2020 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-20-000364 | Jan 2, 2020 | Jan 1, 2020 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-20-000363 | Jan 2, 2020 | Jan 1, 2020 |
| SC 13G | SC 13G | 0000905718-20-000006 | Jan 2, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-326668 | Dec 31, 2019 | — |
| 3 | — | 0000905718-19-001011 | Dec 31, 2019 | Jun 30, 2019 |
| 6-K | FORM 6-K | 0001104659-19-066289 | Nov 21, 2019 | — |
| SC 13G/A | SC 13G/A | 0001178913-19-002775 | Nov 18, 2019 | — |
| 6-K | FORM 6-K | 0001104659-19-064557 | Nov 15, 2019 | — |
| 6-K | FORM 6-K | 0001104659-19-062701 | Nov 12, 2019 | — |
| 6-K | 6-K | 0001104659-19-056658 | Oct 28, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-045656 | Sep 23, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-039629 | Aug 13, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-037764 | Aug 6, 2019 | Aug 5, 2019 |
| S-8 | FORM S-8 | 0001144204-19-035399 | Jul 22, 2019 | — |
| 6-K | 6-K | 0001144204-19-033929 | Jul 8, 2019 | — |
| SC 13D/A | SC 13D/A | 0001144204-19-032515 | Jun 27, 2019 | — |
| SC 13G/A | SC 13G/A | 0001178913-19-001761 | Jun 26, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-031253 | Jun 18, 2019 | — |
| SC 13G | SC 13G | 0001178913-19-001692 | Jun 11, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-028475 | May 28, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-027608 | May 22, 2019 | — |
| 20-F/A | 20-F/A | 0001144204-19-020986 | Apr 24, 2019 | Dec 31, 2018 |
| 20-F | FORM 20-F | 0001144204-19-015792 | Mar 25, 2019 | Dec 31, 2018 |
| 6-K | FORM 6-K | 0001144204-19-013812 | Mar 14, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-013521 | Mar 12, 2019 | — |
| SC 13D/A | PALISADE MEDICAL EQUITY I, LP | 0001085146-19-001003 | Feb 25, 2019 | — |
| SC 13D | SCHEDULE 13D | 0001193125-19-047113 | Feb 21, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-008167 | Feb 14, 2019 | — |
| 424B4 | FINAL PROSPECTUS | 0001144204-19-006795 | Feb 13, 2019 | — |
| 6-K | FORM 6-K | 0001144204-19-006421 | Feb 12, 2019 | — |
| CT ORDER | — | 9999999997-19-000173 | Feb 12, 2019 | — |
| EFFECT | — | 9999999995-19-000166 | Feb 11, 2019 | — |
| CERT | — | 0001354457-19-000064 | Feb 11, 2019 | — |
| UPLOAD | — | 0000000000-19-001764 | Feb 11, 2019 | — |
| CORRESP | — | 0001144204-19-006016 | Feb 11, 2019 | — |
| F-1/A | AMENDMENT NO. 4 TO FORM F-1 | 0001144204-19-006010 | Feb 11, 2019 | — |
| 8-A12B | 8-A12B | 0001144204-19-005893 | Feb 8, 2019 | — |
| F-1/A | AMENDMENT NO. 3 TO FORM F-1 | 0001144204-19-005631 | Feb 8, 2019 | — |
| CORRESP | — | 0001144204-19-005635 | Feb 7, 2019 | — |
| CORRESP | — | 0001144204-19-005634 | Feb 7, 2019 | — |
| CORRESP | — | 0001144204-19-005633 | Feb 7, 2019 | — |
| F-1/A | AMENDMENT NO. 2 TO FORM F-1 | 0001144204-19-005093 | Feb 5, 2019 | — |
| UPLOAD | — | 0000000000-19-000879 | Feb 4, 2019 | — |
| F-1/A | AMENDMENT NO.1 TO FORM F-1 | 0001144204-19-003866 | Jan 31, 2019 | — |
| CORRESP | — | 0001144204-19-000931 | Jan 7, 2019 | — |
| F-1 | FORM F-1 | 0001144204-19-000925 | Jan 7, 2019 | — |
| UPLOAD | — | 0000000000-18-037725 | Dec 11, 2018 | — |